Intelligence / Healthtech / FDA 510(k) Clearances / Vein 360
Approvalsdevice cleared20 Oct 2026
Vein 360
20 Oct 2026: Device cleared · Vein360 Reprocessed LithoVue Digital Flexible Ureteroscope (Standard Deflection); Vein360 Reprocessed LithoVue Digital Flexible Ureteroscope (Reverse Deflection). Recorded in the openFDA device 510(k) data.
- Decided
- 20 Oct 2026
- Device
- Vein360 Reprocessed LithoVue Digital Flexible Ureteroscope (Standard Deflection); Vein360 Reprocessed LithoVue Digital Flexible Ureteroscope (Reverse Deflection)
- Specialty
- Gastroenterology, Urology
- Country
- United States
- Location
- Cincinnati, OH
- Clearance type
- Traditional
- 510(k) number
- K260708
- Submitted
- 2026-03-04
What this signal means
A clearance starts commercialisation: distribution, reimbursement, software and sales hires.
- 268 added in the 30 days to 9 Nov 2026.
- Cardiovascular leads with 122 clearances, then Radiology (107).
Reach them with AOS
Find the decision makers at Vein 360
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
More in Gastroenterology, Urology
FDA 510(k) Clearances
30 OctIntuitive Surgical, Inc.device cleared · da Vinci Xi Surgical System (IS4000);da Vinci X Surgical System (IS4200)Approvals30 OctStrauss Surgical USAdevice cleared · Strauss Surgical Cystoscope/Hysteroscope and Accessories InstrumentsApprovals29 OctBloom Surgical, Inc.device cleared · SWICSApprovals29 OctZhejiang Geyi Medical Instrument Co., Ltd.device cleared · Single-use Digital Flexible Ureteroscope (GY-UR6.3); Single-use Digital Flexible Ureteroscope (GY-UR6.3A)Approvals28 OctColoplast Corp.device cleared · Luja femaleApprovals27 OctTeleflex Medical, LLCdevice cleared · OnControl Powered Bone Access Systems;OnControl Bone Marrow Aspiration System;OnControl Bone Marrow Biopsy System;OnControl Bone Lesion Biopsy System;OnControl Power DriverApprovals
Source: openFDA device 510(k) data, data to 9 Nov 2026. Devices FDA found substantially equivalent and cleared for the US market. Decision dates as published by FDA. AOS shows what the public record says; it does not verify or endorse the company.